Rates of referral to a cardiologist, which markedly improves cardiovascular outcomes, differ significantly based on nonclinical patient characteristics.
Physicians’ ethical obligations to disclose conflicts of interest to patients and to obtain their informed consent for treatment are particularly critical when proposed treatments are experimental.